fenofibrate

fenofibrate

 英

  • 網絡非諾貝特;弗尼利脂寧;血脂藥物

例句

The study found virtually no difference in the risk for amputations above the ankle between those who did and did not take fenofibrate.

研究發現以上截肢風險服用諾貝特服用諾貝特之間顯著差異

The risk of a first amputation was 36 percent lower among people taking fenofibrate than those taking the placebo.

初次截肢風險諾貝特安慰劑降低36%。

Compared with HG group, these changes could be fully or partly reversed by fenofibrate treatment.

比較諾貝特干預完全部分逆轉上述變化

Objective: To explore the protective mechanism of fenofibrate on diabetic nephropathy.

目的探討諾貝特糖尿病腎病保護機制

In ACCORD Lipid, fenofibrate also reduced micro- and macro-albuminuria, markers of diabetic renal disease.

ACCORD脂質研究基金會諾貝特同時降低微觀宏觀尿蛋白二者腎病標志

But the release of fenofibrate from Tricor? tablets or micronized fenofibrate dispersion systems (MDSs) was limited in water medium.

但是對照處方Tricor?tablets藥物分散系統受到限制

This is achieved by adding fenofibrate to simvastatin.

療效通過諾貝特加入取得

Effects of fenofibrate on proliferation and apoptosis induced by lysophosphatidylcholine in cultured human umbilical vein endothelial cells

諾貝特溶血卵磷脂誘導血管內皮細胞增生凋亡影響

Comparison between effect of fenofibrate sustained release pellet capsule and simvastatin in treating combined hyperlipidemia

諾貝特膠囊治療混合比較

Fenofibrate Partly Prevents Oxidized-Low Density Lipoprotein Induced Immune Maturation of Human Monocyte-Derived Dendritic Cell

諾貝特部分阻斷氧化密度脂蛋白誘導單核細胞細胞免疫成熟

Fenofibrate increases endothelial nitric oxide synthase expression in bovine aortic endothelial cells

諾貝特上調血管內皮細胞一氧化合酶表達

Fenofibrate inhibits thrombogenic and fibrinolytic factors expression in adipose tissues

諾貝特脂肪組織凝血纖溶因子表達影響

Upper gastrointestinal hemorrhage associated with concomitant use of warfarin, losartan potassium, fenofibrate and allopurinol

華法林沙坦諾貝特別嘌伍用消化出血

Fenofibrate Inhibiting Tissue Factor Expression in Adipocytes

諾貝特抑制脂肪細胞組織因子表達

Regulatory effects of pioglitazone and fenofibrate on body fat distribution and energy homeostasis in SD rats

格列諾貝特SD分布能量代謝調節作用

Comparison of effect of fenofibrate and rosiglitazone on levels of serum lipid, body weight and insulin sensitivity in rats

諾貝特羅格列大鼠血脂體重胰島素敏感性作用比較

Effect of Polymorphism of Human Intestinal Fatty Acid Binding Protein Gene on the Therapeutic Efficacy of Fenofibrate

小腸脂肪酸結合蛋白基因多態性諾貝特血脂作用影響

Fenofibrate: a review of its use in primary dyslipidaemia, the metabolic syndrome and type 2 diabetes mellitus

綜述諾貝特初期血脂障礙代謝綜合2糖尿病應用

Inhibition effect of fenofibrate on vascular remodeling after coronary artery injury

諾貝特冠狀動脈損傷血管重構抑制效果

Efficacy and safety of combined therapy with simvastatin and fenofibrate for type 2 diabetes patients with mixed hyperlipidemia

聯合諾貝特治療2糖尿病混合療效安全性觀察

Preparation of Fenofibrate Solid Dispersion Tablets

諾貝特固體分散試制

Effects of Fenofibrate on neonatal rat hypertrophic cardiomyocyte in vitro

諾貝特新生大鼠肥大心肌細胞影響

Observation of Simvastatin Plus Fenofibrate for the Treatment of 42 Patients with Mixed Hyperlipemia

聯合諾貝特治療混合42療效觀察

Study on the Determination of Fenofibrate by Single - sweep Polarography

掃描極譜測定諾貝特研究

Therapy effects of fenofibrate on alcoholic fatty liver and drug-induced fatty liver in rats

諾貝特治療酒精性藥物脂肪實驗研究

Effect of Fenofibrate on the reaction levels of triglyceride of CHD patients after high-fat diet

微粒諾貝特冠心病血清甘油三反應水平影響

The protective effect of fenofibrate on the kidney in experimental diabetic rats

諾貝特實驗糖尿病大鼠腎臟保護作用研究

Lipotoxicity of palmitic acid on islets and protecting effect of fenofibrate

棕櫚脂毒性諾貝特保護作用